A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection. - Mayer, K. A.; Schrezenmeier, E.; Diebold, M.; Halloran, P. F.; Schatzl, M.; Schranz, S.; Haindl, S.; Kasbohm, S.; Kainz, A.; Eskandary, F.; Doberer, K.; Patel, U. D.; et al. (New England Journal of Medicine, 2024)